We recently found that endocannabinoid signaling appears to be dysregulated in the cerebellum SCA patients (including SCA-3), with important alterations to CB1 and CB2 receptors [15], and to FAAH and MAGL enzymes in post-mortem tissue [16]. Here, FAAH is linked to Spinocerebellar ataxia type 3.